Latest filings (excl ownership)
SC TO-T/A
Third party tender offer statement (amended)
10 May 24
SC TO-T/A
Third party tender offer statement (amended)
8 May 24
SC TO-T/A
Third party tender offer statement (amended)
7 May 24
SC TO-T/A
Third party tender offer statement (amended)
6 May 24
SC TO-T/A
Third party tender offer statement (amended)
2 May 24
SC TO-T/A
Third party tender offer statement (amended)
25 Apr 24
6-K
Current report (foreign)
23 Apr 24
SC TO-T/A
Third party tender offer statement (amended)
18 Apr 24
SC TO-T/A
Third party tender offer statement (amended)
17 Apr 24
SC TO-T/A
Third party tender offer statement (amended)
16 Apr 24
SC TO-T/A
Third party tender offer statement (amended)
15 Apr 24
SC TO-T
Third party tender offer statement
11 Apr 24
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Feb 24
SC TO-C
Information about tender offer
6 Feb 24
SC TO-C
Information about tender offer
5 Feb 24
6-K
Current report (foreign)
31 Jan 24
6-K
Current report (foreign)
31 Jan 24
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
31 Jan 24
20-F
2023 FY
Annual report (foreign)
31 Jan 24
6-K
Current report (foreign)
8 Jan 24
6-K
Current report (foreign)
11 Dec 23
6-K
Current report (foreign)
5 Dec 23
6-K
Current report (foreign)
28 Nov 23
6-K
Current report (foreign)
30 Oct 23
6-K
Current report (foreign)
24 Oct 23
6-K
Current report (foreign)
4 Oct 23
6-K
Current report (foreign)
2 Oct 23
6-K
Current report (foreign)
5 Sep 23
6-K
Current report (foreign)
21 Aug 23
6-K
Current report (foreign)
9 Aug 23
6-K
Current report (foreign)
18 Jul 23
DFAN14A
Additional proxy materials by non-management
10 Jul 23
6-K
Current report (foreign)
10 Jul 23
DFAN14A
Additional proxy materials by non-management
12 Jun 23
6-K
Current report (foreign)
12 Jun 23
SD
Conflict minerals disclosure
31 May 23
UPLOAD
Letter from SEC
22 May 23
20-F/A
2022 FY
Annual report (foreign) (amended)
15 May 23
CORRESP
Correspondence with SEC
9 May 23
6-K
Current report (foreign)
25 Apr 23
Latest ownership filings
SC 13D
MorphoSys AG
18 Apr 24
SC 13G/A
BlackRock Inc.
2 Feb 24
144
Notice of proposed sale of securities
19 Sep 23
SC 13G/A
BlackRock Inc.
1 Feb 23
3
PHARMA AG NOVARTIS
27 Jun 22
SC 13G
BlackRock Inc.
4 Feb 22
SC 13G/A
XOMA Corp
19 Aug 20
3
Cellular Biomedicine Group, Inc.
14 Aug 20
4
PHARMA AG NOVARTIS
16 Jul 20
3
PHARMA AG NOVARTIS
13 Jul 20
4
Akouos, Inc.
2 Jul 20
3
Akouos, Inc.
25 Jun 20
4
Galera Therapeutics, Inc.
22 Jun 20
3
Forma Therapeutics Holdings, Inc.,
18 Jun 20
4
Galera Therapeutics, Inc.
17 Jun 20
4
Galera Therapeutics, Inc.
12 Jun 20
4
Galera Therapeutics, Inc.
9 Jun 20
4
Galera Therapeutics, Inc.
4 Jun 20
4
Galera Therapeutics, Inc.
12 Nov 19
3
Galera Therapeutics, Inc.
6 Nov 19
4
BICYCLE THERAPEUTICS plc
30 May 19
3
BICYCLE THERAPEUTICS Ltd
22 May 19
4
Aerpio Pharmaceuticals, Inc.
29 Apr 19
4
Aerpio Pharmaceuticals, Inc.
24 Apr 19
4
Aerpio Pharmaceuticals, Inc.
15 Apr 19
4
Aerpio Pharmaceuticals, Inc.
10 Apr 19
4
Aerpio Pharmaceuticals, Inc.
5 Apr 19
4
AILERON THERAPEUTICS INC
2 Apr 19
4
Aerpio Pharmaceuticals, Inc.
2 Apr 19
4
Aerpio Pharmaceuticals, Inc.
28 Mar 19
4
AILERON THERAPEUTICS INC
15 Mar 19
5
Intellia Therapeutics, Inc.
14 Feb 19
4
Altimmune, Inc.
4 Oct 18
4
Altimmune, Inc.
14 Sep 18
4
Aerpio Pharmaceuticals, Inc.
22 Aug 18
4
AILERON THERAPEUTICS INC
22 Aug 18
4
AILERON THERAPEUTICS INC
20 Aug 18
4
AILERON THERAPEUTICS INC
16 Aug 18
4
AILERON THERAPEUTICS INC
14 Aug 18
4
AILERON THERAPEUTICS INC
10 Aug 18